| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Department of Pathology, University of Michigan Medical School, Ann Arbor, MI 48109
Respiratory syncytial virus (RSV) is the leading cause of respiratory disease in infants worldwide. The induction of innate immunity and the establishment of adaptive immune responses are influenced by the recognition of pathogen-associated molecular patterns by TLRs. One of the primary pathways for TLR activation is by MyD88 adapter protein signaling. The present studies indicate that MyD88 deficiency profoundly impacts the pulmonary environment in RSV-infected mice characterized by the accumulation of eosinophils and augmented mucus production. Although there was little difference in CD4 T cell accumulation, there was also a significant decrease in conventional dendritic cells recruitment to the lungs of MyD88–/– mice. The exacerbation of RSV pathophysiology in MyD88–/– mice was associated with an enhanced Th2 cytokine profile that contributed to an inappropriate immune response. Furthermore, bone marrow-derived dendritic cells (BMDC) isolated from MyD88–/– mice were incapable of producing two important Th1 instructive signals, IL-12 and delta-like4, upon RSV infection. Although MyD88–/– BMDCs infected with RSV did up-regulate costimulatory molecules, they did not up-regulate class II as efficiently and stimulated less IFN-
from CD4+ T cells in vitro compared with wild-type BMDCs. Finally, adoptive transfer of C57BL/6 BMDCs into MyD88–/– mice reconstituted Th1 immune responses in vivo, whereas transfer of MyD88–/– BMDCs into wild-type mice skewed the RSV responses toward a Th2 phenotype. Taken together, our data indicate that MyD88-mediated pathways are essential for the least pathogenic responses to this viral pathogen through the regulation of important Th1-associated instructive signals.
The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked advertisement in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
1 This work was supported in part by National Institutes of Health Grant AI36302.
2 Address correspondence and reprint requests to Dr. Nicholas W. Lukacs, Department of Pathology, University of Michigan Medical School, 1301 Catherine, 5214 Medical Science 1, Ann Arbor, MI 48109. E-mail address: nlukacs{at}umich.edu
3 Abbreviations used in this paper: RSV, respiratory syncytial virus; DC, dendritic cell; BAL, bronchioalveolar lavage; BMDC, bone marrow DC; qPCR, quantitative PCR.
This article has been cited by other articles:
|
|
 |
|
  K. D. Dyer, C. M. Percopo, E. R. Fischer, S. J. Gabryszewski, and H. F. Rosenberg Pneumoviruses infect eosinophils and elicit MyD88-dependent release of chemoattractant cytokines and interleukin-6 Blood, September 24, 2009; 114(13): 2649 - 2656. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. R. Murawski, G. N. Bowen, A. M. Cerny, L. J. Anderson, L. M. Haynes, R. A. Tripp, E. A. Kurt-Jones, and R. W. Finberg Respiratory Syncytial Virus Activates Innate Immunity through Toll-Like Receptor 2 J. Virol., February 1, 2009; 83(3): 1492 - 1500. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V. G. Bhoj, Q. Sun, E. J. Bhoj, C. Somers, X. Chen, J.-P. Torres, A. Mejias, A. M. Gomez, H. Jafri, O. Ramilo, et al. MAVS and MyD88 are essential for innate immunity but not cytotoxic T lymphocyte response against respiratory syncytial virus PNAS, September 16, 2008; 105(37): 14046 - 14051. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. A. Schaller, R. Neupane, B. D. Rudd, S. L. Kunkel, L. E. Kallal, P. Lincoln, J. B. Lowe, Y. Man, and N. W. Lukacs Notch ligand Delta-like 4 regulates disease pathogenesis during respiratory viral infections by modulating Th2 cytokines J. Exp. Med., November 26, 2007; 204(12): 2925 - 2934. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
